Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract Ulcerative colitis (UC) belongs to chronic inflammatory disease with a relapsing characterization. Conventional oral drugs of UC are restricted in clinical by premature degradation in the gastrointestinal tract, modest efficacy, and adverse effects. CX5461 can treat autoimmune disease, immu...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2024-10-01
|
| סדרה: | Journal of Nanobiotechnology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12951-024-02856-z |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
